Certain viral variants may be less susceptible to a COVID vaccine and treatments
In recent months, studies have raised the possibility that certain emerging SARS-CoV-2 variants evolved to escape antibody immune surveillance, elicited by previous infection, immunization, or by monoclonal antibody treatments.